Literature DB >> 8016060

[The use of antioxidants (alpha-tocopherol acetate) in the treatment of diabetes mellitus].

N S Kuznetsov, A M Abulela, V N Neskoromnyĭ.   

Abstract

The authors have examined the time course of lipid peroxidation processes and the levels of total lipids in red cell membranes and blood plasma of diabetics administered alpha-tocopherol acetate. Patients with medium-severe diabetes of the first and second types were divided into 2 groups. Group 1 patients were administered only traditional sugar-reducing treatment, in Group 2 alpha-tocopherol acetate in a daily dose 300 mg was added to such therapy. Similar examinations were carried out in both the groups before and after the treatment. Lipid peroxidation levels and the content of total lipids were found significantly increased in the cellular membranes and blood plasma of Group 2 patients, whereas in Group 1 no changes of this kind were detected. Therapy with alpha-tocopherol acetate normalized lipid peroxidation processes in the red cell membranes and the total lipid content in the blood plasma, reduced the blood plasma level of lipid peroxidation products and the content of total lipids in red cell membranes. These results permit a conclusion on the favorable effect of alpha-tocopherol acetate on blood plasma lipid peroxidation and total lipid levels in diabetics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8016060

Source DB:  PubMed          Journal:  Probl Endokrinol (Mosk)        ISSN: 0375-9660


  2 in total

1.  Vitamin E, Its Beneficial Role in Diabetes Mellitus (DM) and Its Complications.

Authors:  Anand Baburao Jain; Vaishali Anand Jain
Journal:  J Clin Diagn Res       Date:  2012-09-01

Review 2.  Therapeutic Efficacy of Antioxidants in Ameliorating Obesity Phenotype and Associated Comorbidities.

Authors:  Steven Tun; Caleb James Spainhower; Cameron Lee Cottrill; Hari Vishal Lakhani; Sneha S Pillai; Anum Dilip; Hibba Chaudhry; Joseph I Shapiro; Komal Sodhi
Journal:  Front Pharmacol       Date:  2020-08-13       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.